To expand upon our observations in cellular models and capitalize on our high-throughput assays, we assessed whether the LRRK2 protective haplotype modulates LRRK2 levels or activity in PBMCs obtained from healthy subjects and PD patients with and without the LRRK2 N551K R1398H variant. This evidence concerns the gene LRRK2 and Parkinson disease.